After one of the participants contracted an "unexplained disease"

"AstraZeneca" suspends clinical trials of the Oxford vaccine against "Corona"

AstraZeneca’s experiments will be suspended until an independent committee evaluates the proposal, about which it has not provided details.

Archives

AstraZeneca, a pharmaceutical group, suspended the clinical trials of one of the most advanced experimental vaccines it is developing with the University of Oxford, the night before last.

To find out one of the potentially dangerous side effects of a participant, the British-Swedish "AstraZeneca", a partner of the University of Oxford in Britain, announced the suspension of clinical trials of its vaccine against "Covid-19" in several countries in the world, including Britain and the United States, after one of the participants in these trials was infected with "An unexplained disease."

The trials will be suspended until an independent committee evaluates the offer, about which it did not give details, and is likely to be a dangerous side offer.

According to the "State News" website, which specializes in it, the trials were suspended "on the suspicion of a serious side effect of a participant in Britain."

University of California Riverside professor David Law said that "other side effects" were recorded "such as fever and pain, so the matter may be more serious."

"Trials are often suspended temporarily, when a side effect appears in a patient, so that the researchers can inform" the sites where the experiments are being conducted, he added.

He explained, "It is most likely that the goal, now, is to exercise caution. It is a comment, and it is not as if we say we cannot progress."

This comment may delay one of the most advanced western projects, as well as those of the two American companies: Moderna and Pfizer, each of which has recruited tens of thousands of people to verify the safety of doses and prevent people who have been vaccinated from contracting the "Covid-19" epidemic.

The three companies had said, until now, that they hoped to obtain results before the end of the year or early 2021, and began producing millions of doses in advance, in case the results were successful.

AstraZeneca has already sold hundreds of millions of doses to many countries in the world than any of its competitors.

Mexico, which is participating with Argentina in the production and distribution of the possible "AstraZeneca" vaccine in Latin America, announced the possibility of delaying its use.

Mexican Health Minister Hugo Lopez Gatel said, during a press conference, that the suspension of clinical trials "is not an uncommon occurrence, and therefore the arrival of the vaccine in the region may be delayed."

In the United States, the most affected country in the world, many experts fear that the US President, Donald Trump, will press for a license to use a vaccine against Corona before the presidential elections on the third of November.

Trump confirmed that his country will develop a vaccine "this year."

As for his Democratic opponent, Joe Biden, last Monday, he said that he "wants to listen to the views of scientists", and the country's health authorities confirmed that the approval process for a possible vaccine will be based on scientific results.

In the face of the escalating controversy, the managers of nine companies that develop vaccines sought to reassure the public, by signing a joint pledge to adhere to the results of clinical trials before granting a license.

And the competition is most intense to develop a vaccine.

In early August, Russia announced the development of the "first" vaccine against "Covid-19", and 20 foreign countries asked them, in advance, to purchase more than "one billion doses", according to the Russian sovereign fund co-financing it.

AstraZeneca has already sold hundreds of millions of doses to many countries in the world than any of its competitors.

Follow our latest local and sports news, and the latest political and economic developments via Google news